Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated HIV-1 Infected Controllers HIV-1 Infection

Drug: Vesatolimod;

Drug: Vesatolimod Placebo;  

Drug: ART
A Randomized, Double-blind, Placebo-controlled Trial, Followed by Single-arm Treatment of PRO 140 in Combination w/ Optimized Background Therapy in Treatment-Experienced HIV Subjects HIV

Drug: PRO 140;  

Drug: Placebo;

Drug: Optimized Background Regimen

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Adults (PRIOH-1)

 HSV Herpes

Drug: Pritelivir

Drug: Foscarnet 
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection HIV Drug: PRO 140
A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care HIV-1 Drug: DRV 800 mg + COBI 150 mg + FTC 200 mg + TAF 10 mg FDC